A new clinical trial found a cheaper generic drug is effective in protecting the heart in boys with Duchenne muscular dystrophy.
Researchers investigate an unusual case of concurrent genetic and somatic diagnoses.
A study suggests doses could be tailored to each particular patient’s injury.
Patients with cystic fibrosis show transcriptomic changes after starting treatment with lumacaftor/ivacaftor.
A quality improvement project shows that skin-to-skin care can be safely integrated into the treatment of infants who require surgery.
Randomized, controlled clinical trials are needed to answer questions regarding when and with whom to use the device.
Data from The Pediatric Heart Network Normal Echocardiogram Database show interobserver variability, especially in younger and smaller patients.
